Want to see JP:2413 full AI Analyst Report?
2413 Stock Chart & Stats
¥1834.00
¥16.00(0.84%)
At close: 4:00 PM EDT
¥1834.00
¥16.00(0.84%)
Day’s Range― - ―
52-Week Range¥1,297.00 - ¥2,746.00
Previous CloseN/A
Volume3.52M
Average Volume (3M)3.08M
Market Cap
¥1.19T
Enterprise Value¥1.12T
Total Cash (Recent Filing)¥162.17B
Total Debt (Recent Filing)¥37.56B
Price to Earnings (P/E)25.5
Beta0.51
Next Earnings
Oct 22, 2026EPS Estimate
18.84Next Dividend Ex-DateN/A
Dividend Yield1.25%
Share Statistics
EPS (TTM)68.68
Shares Outstanding679,127,600
10 Day Avg. Volume2,232,180
30 Day Avg. Volume3,075,440
Financial Highlights & Ratios
PEG Ratio1.02
Price to Book (P/B)2.66
Price to Sales (P/S)3.09
P/FCF Ratio17.37
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
¥2,010.00Price Target Upside9.60% Upside
Rating ConsensusHold
Number of Analyst Covering8
EPS Forecast (FY)77.89
Revenue Forecast (FY)¥389.15B
Bulls Say, Bears Say
Bulls Say
Re-accelerating Revenue GrowthThe return to double-digit revenue growth indicates renewed demand for M3’s healthcare information, marketing, research, and related platforms. If sustained, this expansion can broaden network monetization, support operating investment, and reinforce the company’s position across healthcare-sector digital services.
Conservative Balance SheetVery low leverage gives M3 substantial financial flexibility and reduces the burden of interest or refinancing obligations. Growing equity provides a stronger base for investment in platforms and healthcare solutions, while the conservative structure improves resilience if industry demand or client spending weakens.
Strong Free Cash Flow GenerationFree cash flow that closely tracks reported earnings supports the quality of M3’s profits and gives management internally generated funds for product development, hiring, acquisitions, or shareholder returns. This cash generation can help sustain growth without requiring greater financial leverage.
Bears Say
Margin CompressionAlthough profitability remains healthy, the multi-year margin decline signals that M3 is retaining less profit from each unit of revenue than at its earlier peak. Continued pressure from costs or business mix could limit earnings growth and reduce the operating leverage of future platform expansion.
Uneven Operating Cash ConversionOperating cash flow below accounting earnings indicates that reported profits are not converting fully into operating cash in recent periods. The pack attributes this to possible working-capital or timing drag, which could make funding capacity less predictable even though free cash flow remains strong overall.
Earnings Below Prior PeakThe recovery in net income is encouraging, but earnings have not yet regained their earlier high-water mark. This suggests that revenue momentum has not fully restored prior earnings power, and the company may need stronger growth or improved margins to deliver a durable expansion in profits.
M3 News
2413 FAQ
What was M3 Inc’s price range in the past 12 months?
M3 Inc lowest stock price was ¥1297.00 and its highest was ¥2746.00 in the past 12 months.
What is M3 Inc’s market cap?
M3 Inc’s market cap is ¥1.19T.
When is M3 Inc’s upcoming earnings report date?
M3 Inc’s upcoming earnings report date is Oct 22, 2026 which is in 17 days.
How were M3 Inc’s earnings last quarter?
M3 Inc released its earnings results on Aug 06, 2026. The company reported ¥13.6 earnings per share for the quarter, missing the consensus estimate of ¥20.087 by -¥6.487.
Is M3 Inc overvalued?
According to Wall Street analysts M3 Inc’s price is currently Undervalued.
Does M3 Inc pay dividends?
M3 Inc pays a Annually dividend of ¥22 which represents an annual dividend yield of 1.25%. See more information on M3 Inc dividends here
What is M3 Inc’s EPS estimate?
M3 Inc’s EPS estimate is 18.84.
How many shares outstanding does M3 Inc have?
M3 Inc has 679,127,600 shares outstanding.
What happened to M3 Inc’s price movement after its last earnings report?
M3 Inc reported an EPS of ¥13.6 in its last earnings report, missing expectations of ¥20.087. Following the earnings report the stock price went up 6.11%.
Which hedge fund is a major shareholder of M3 Inc?
Currently, no hedge funds are holding shares in JP:2413
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
M3 Inc
M3, Inc. is a Japanese company that delivers a broad spectrum of internet-based services, predominantly catering to medical professionals and the broader healthcare industry. Its operations are segmented into five key areas: Medical Platform, Evidence Solution, Career Solution, Site Solution, and Overseas. M3 manages several specialized online platforms, including m3.com, an exclusive information portal for healthcare professionals; MR-kun, which ensures member doctors receive ongoing updates via the m3com platform; QOL-kun, offering non-medical life support; and AskDoctors, where certified physicians address public health inquiries from the general public. Internationally, it operates MDLinx for U.S. medical professionals and Doctorsnetuk, a U.K.-based site supporting pharmaceutical companies and providing drug information databases across France, Germany, and Spain. Furthermore, M3 offers dedicated career services for doctors and pharmacists through its m3com CAREER platform. Its diverse business portfolio extends to sales and marketing for pharmaceutical and medical device companies, as well as the development, sale, and maintenance of electronic medical records and equipment for healthcare facilities. M3 also conducts surveys for medical professionals, offers online sales and marketing assistance to pharmaceutical firms, provides management consulting to medical institutions, delivers home-visit nursing services, and specializes in human resource solutions for healthcare staff, alongside managing clinical trial facilities. Established in 2000, the company was initially named So-netM3, Inc., before rebranding to M3, Inc. in January 2010. Its headquarters are located in Tokyo, Japan.
2413 Stock 12 Month Forecast
Average Price Target
¥2,010.00
▲(9.60% Upside)